CLINICAL TRIALS IN UKRAINE: STATUS QUO AND OPPORTUNTIES

HOME NEWS CLINICAL TRIALS IN UKRAINE: STATUS QUO AND OPPORTUNTIES
CLINICAL TRIALS IN UKRAINE: STATUS QUO AND OPPORTUNTIES

🔊 FIRST CALL! LIVE WEBINAR
📈 CLINICAL TRIALS IN UKRAINE: STATUS QUO AND OPPORTUNITIES
📅 Monday, February 5, 2024
⏰ 5:00 PM CET / 11:00 AM EDT / 8:00 AM PDT

ARENSIA is excited to invite you to an exclusive 90-minute online session, offering valuable insights into Ukraine's current clinical trial landscape and highlighting the advantages of initiating new studies in the region.

WHAT TO EXPECT:

Ukraine is witnessing increased engagement from major pharmaceutical and biotech firms, reflecting a broader industry strategy to reach underserved populations. To facilitate clinical trials, Ukrainian Health Authorities have streamlined legislation, reducing approval timelines to just 35 days.

Kyiv remains a secure hub for clinical trials, boasting uninterrupted operations in essential systems and infrastructure for over a year. ARENSIA clinics in downtown Kyiv have thrived amid the conflict since February 2022, demonstrating exceptional performance in patient enrollment, safety, and data quality.

Join us on February 5th to hear from esteemed speakers sharing experiences in launching and managing clinical trials in Ukraine.

www.arensia-em.com/events-1-clinical-trials-in-ukraine-status-quo-and-opportunities

10.01.2024
CONTACT US